Previous 10 | Next 10 |
Ra Medical Systems, Inc. (NYSE American: RMED) , a medical device company focusing on developing its excimer laser system to treat vascular diseases, today announced the closing of an underwritten public offering of units and pre-funded units for aggregate gross proceeds of approxim...
Ra Medical Systems (NYSE:RMED) slumps 52.2% in premarket after pricing its underwritten public offering of units for gross proceeds of ~$12M. Offering consists of 9.54M units priced at a public offering price of $0.50/unit wherein each unit consists of one share, two ...
Ra Medical Systems, Inc. (NYSE American: RMED) , a medical device company focusing on developing its excimer laser system to treat vascular diseases, today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $12.0 million prior to de...
Ra Medical Systems, Inc. (NYSE American: RMED) announces that Chief Executive Officer Will McGuire has issued the following Letter to Stockholders: To My Fellow Stockholders: I’m very proud of the Ra Medical team’s significant progress in implementing engineeri...
Ra Medical Systems, Inc. (RMED) Q3 2021 Earnings Conference Call November 15, 2021 16:30 ET Corporate Participants Jody Cain - LHA Investor Relations Will McGuire - Chief Executive Officer Andrew Jackson - Chief Financial Officer Conference Call Participants Vernon Bernardino - HC Wainwright ...
Ra Medical Systems (NYSE:RMED): Q3 GAAP EPS of -$1.15 misses by $0.36. Revenue of $5K (-92.6% Y/Y) Press Release Ra Medical reported cash and cash equivalents of $20.6 million as of September 30, 2021. For further details see: Ra Medical Systems EPS misses by $0.36
Conference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc . (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three and nine months ended Septe...
Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report third quarter 2021 financial results after market close on Monday, November 15. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern ...
Protagonist Therapeutics (NASDAQ:PTGX) +89% after FDA removes clinical hold on rusfertide program Flexion Therapeutics (NASDAQ:FLXN) +73% Pacira Therapeutics acquires Flexion Therapeutics for $8.50 per share in cash plus one CVR Adamas Pharmaceuticals (NASDAQ:ADMS) +7...
Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular diseases, announces that management will present at the virtual H.C. Wainwright 23 rd Annual Global Investment Conference being held Septem...
News, Short Squeeze, Breakout and More Instantly...
Ra Medical Systems Inc. Company Name:
RMED Stock Symbol:
NYSE Market:
Ra Medical Systems Inc. Website:
Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023 FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced that its Board of Directors has approved cha...
First patent out of six applications on file for LockeT product FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Ent...
Catheter Precision's VIVO System Has Been Utilized in over 1,000 Procedures FORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricula...